Novartis AG (LON:0QLR)

Novartis AG Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 29, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	207,934	156,316	162,643	161,382	145,494	157,509
Market Cap Growth	28.68%	-3.89%	0.78%	10.92%	-7.63%	-2.92%
Enterprise Value	225,104	170,040	173,261	169,844	165,439	178,432
Last Close Price	108.36	75.37	73.18	64.01	52.92	55.16
PE Ratio	19.42	16.39	13.95	27.96	8.20	26.64
PS Ratio	4.96	3.78	4.44	4.47	4.48	4.31
PB Ratio	6.25	4.43	4.43	3.27	2.91	3.80
P/TBV Ratio	-	-	-	69.00	21.01	-
P/FCF Ratio	14.28	12.04	15.46	14.60	14.07	17.38
P/OCF Ratio	13.26	11.11	14.33	13.66	13.07	15.75
EV/Sales Ratio	5.30	4.12	4.73	4.71	5.09	4.88
EV/EBITDA Ratio	11.86	10.30	12.60	14.68	14.33	16.32
EV/EBIT Ratio	14.61	13.04	17.46	22.21	20.43	24.00
EV/FCF Ratio	15.46	13.10	16.47	15.36	16.00	19.69
Debt / Equity Ratio	0.72	0.71	0.57	0.47	0.46	0.67
Debt / EBITDA Ratio	1.27	1.50	1.49	1.97	1.95	2.49
Debt / FCF Ratio	1.64	1.93	1.97	2.10	2.22	3.08
Asset Turnover	0.54	0.51	0.43	0.35	0.34	0.41
Inventory Turnover	2.17	2.20	1.84	1.67	1.65	2.31
Quick Ratio	0.58	0.79	0.88	1.00	1.25	0.65
Current Ratio	0.88	1.03	1.16	1.29	1.51	0.90
Return on Equity (ROE)	32.62%	26.27%	16.15%	9.51%	36.80%	14.38%
Return on Assets (ROA)	12.13%	10.09%	7.27%	4.62%	5.28%	5.16%
Return on Invested Capital (ROIC)	26.53%	23.55%	18.59%	11.14%	13.29%	10.58%
Return on Capital Employed (ROCE)	27.20%	22.20%	17.20%	10.40%	10.80%	10.70%
Earnings Yield	5.15%	6.10%	7.17%	3.58%	12.19%	3.75%
FCF Yield	7.00%	8.30%	6.47%	6.85%	7.11%	5.75%
Dividend Yield	2.68%	4.09%	4.21%	4.49%	4.75%	4.50%
Payout Ratio	56.55%	63.85%	48.85%	107.92%	30.67%	86.56%
Buyback Yield / Dilution	3.84%	2.73%	4.78%	2.79%	1.57%	0.99%
Total Shareholder Return	6.50%	6.82%	8.98%	7.27%	6.31%	5.50%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.